


Healthcare News Roundup: Ophthalmology
HSMN NewsFeed - 16 Apr 2012
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
